1World Health Organization. Companion handbook to the WHO guidelines for the programmatic management of drug-re- sistant tuberculosis. WHO/HTM/TB/2014.11. Geneva: World Health Organization, 2014.
2World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis; emergency update 2008. WHO/HTM/TB/2008. 402. Geneva:World Health Or- ganization, 2008.
3Andres S, Hillemann D, Rtisch-Gerdes S, et al. Occurrence of rpoB mutations in isoniazid-resistant but rifampin-susceptible Mycobacterium tuberculosis isolates from Germany. Antimicrob Agents Chemother, 2014,58(1) ~ 590-592.
4Williamson DA, Roberts SA, Bower JE, et al. Clinical fai- lures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis. Int J Tuberc Lung Dis, 2012,16(2) ..216-220.
